Cited by 28Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesMedical Imaging and Pathology Studies

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

Open access
Jo, Helen E., Glaspole, Ian, Goh, Nicole, Hopkins, Peter M.A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, Eugene Haydn +19 more·2019·Respirology

Abstract

Background and objective: Current guidelines for the diagnosis of idiopathic pulmonary fibrosis (IPF) provide specific criteria for diagnosis in the setting of multidisciplinary discussion (MDD). We evaluate the utility and reproducibility of these diagnostic guidelines, using clinical data from the Australian IPF Registry. Methods: All patients enrolled in the registry undergo a diagnostic review whereby international IPF guidelines are applied via a registry MDD. We investigated the clinical applicability of these guidelines with regard to: (i) adherence to guidelines, (ii) Natural history of IPF diagnostic categories and (iii) Concordance for diagnostic features. Results: A total of 417 participants (69% male, 70.6 ± 8.0 years) with a clinical diagnosis of IPF underwent MDD. The 23% of participants who did not meet IPF diagnostic criteria displayed identical disease behaviour to those with confirmed IPF. Honeycombing on radiology was associated with a worse prognosis and this translated into poorer prognosis in the ‘definite’ IPF group. While there was moderate agreement for IPF diagnostic categories, agreement for specific radiological features, other than honeycombing, was poor. Conclusion: In clinical practice, physicians do not always follow IPF diagnostic guidelines. We demonstrate a cohort of IPF patients who do not meet IPF diagnostic guideline criteria, based largely on their radiology and lack of lung biopsy, but who have outcomes identical to those with IPF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/resp.13427

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [4]4. King TE, Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, Group AS. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. The New England journal of medicine. 2014; 370: 2083-92.
  2. [5]5. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, Investigators IT. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. The New England journal of medicine. 2014; 370: 2071-82.
  3. [32]32. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Jr., Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, Group CS. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011; 377: 1760-9.
  4. [35]35. Jo, H. E., Glaspole, I., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., Allan, H., Macansh, S., Grainge, C., Keir, G. J., Hayen, A., Henderson, D., Klebe, S., Heinze, S. B., Miller, A., Rouse, H. C. ,... Corte, T. J. (2019). Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. RESPIROLOGY, 24 (4), pp.361-368. https://doi.org/10.1111/resp.13427. Persistent Link: http://hdl.handle.net/11343/284694

Cited by

Sorted by citations

Authors
Jo, H. E., Glaspole, I., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., Allan, H., Macansh, S., Grainge, C., Keir, G. J., Hayen, A., Henderson, D., Klebe, S., Heinze, S. B., Miller, A., Rouse, H. C., Duhig, E., Cooper, W. A., Mahar, A. M., Ellis, S., McCormack, S. R., Ng, B., Godbolt, D. B., & Corte, T. J.
Affiliations
  • The University of Sydney (AU)
  • Austin Hospital (AU)
  • Royal Adelaide Hospital (AU)
  • Royal Brisbane and Women's Hospital (AU)
  • Lung Foundation Australia (AU)
  • Princess Alexandra Hospital (AU)
  • University of Technology Sydney (AU)
  • Flinders Medical Centre (AU)
  • The Royal Melbourne Hospital (AU)
  • Royal North Shore Hospital (AU)
  • St Vincent's Hospital Melbourne (AU)
  • Sullivan Nicolaides Pathology (AU)
  • Royal Prince Alfred Hospital (AU)
  • The Alfred Hospital (AU)
  • Prince Charles Hospital (AU)
Corresponding author
Jo, Helen E.
Venue
Respirology
Publisher
Wiley
Published
2018-10-17
Volume
24
Issue
4
Pages
361-368
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W2895937407
Cited by
28
References
29
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 10 · 2019: 4 · 2018: 1
FWCI
3.58
Type
journal article
Language
en
Open access
Locations
  • Respirology (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • UTAS Research Repository (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Funders
National Health and Medical Research Council (APP1066128)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Medical Imaging and Pathology Studies
Keywords
idiopathic pulmonary fibrosis, diagnostic criteria, multidisciplinary discussion, guideline adherence, diagnostic agreement, honeycombing, radiological features, lung biopsy, natural history (disease), prognosis
MeSH terms
Aged, Australia, Biopsy, Female, Humans, Lung, Male, Middle Aged, Prognosis, Registries, Radiography, Thoracic, Reproducibility of Results, Cohort Studies, Practice Guidelines as Topic, Guideline Adherence, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review